Form 4 Tracker
Monopar Therapeutics
MNPR

8 insider filings · Latest: Jun 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 8, 2026Jul 10 10:01 PMArthur Klausner
Proposed Sale
5,000$95.39$477.0K

View →

Jul 7, 2026Jul 7 6:28 PMArthur Klausner
Proposed Sale
5,000$97.05$485.3K

View →

Dec 18, 2025Dec 19 9:00 PMArthur Klausner
Proposed Sale
5,121$67.16$343.9K

View →

Jul 14, 2025Jul 14 4:29 PMSTARR CHRISTOPHER M
Proposed Sale
16,800$40.00$672.0K

View →

Jul 14, 2025Jul 14 4:26 PMTsuchimoto Kim R
Proposed Sale
8,904$40.00$356.2K

View →

Jul 14, 2025Jul 14 4:21 PMRobinson Chandler
Proposed Sale
16,800$40.00$672.0K

View →

Apr 2, 2025Apr 2 3:45 PMTactic Pharma LLC
Proposed Sale
33,334$35.00$1.2M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 30, 2026Jul 2 11:38 PMQuan Anh VuChief Financial Officer
Option Exercise
1,2288,598(D)

View →

Jun 30, 2026Jul 2 11:38 PMChandler RobinsonDirector, Chief Executive Officer
Option Exercise
12,87393,403(D)

View →

Jun 30, 2026Jul 2 11:37 PMAndrew CittadineChief Operating Officer
Option Exercise
5,25439,499(D)

View →

Jun 26, 2026Jun 30 8:57 PMNicole SweenyDirector
Grant/Award
1,284$87.681,284(D)

View →

Mar 31, 2026Apr 2 7:03 PMChandler RobinsonDirector, Chief Executive Officer
Option Exercise
6,732106,276(D)

View →

Mar 31, 2026Apr 2 7:03 PMAndrew CittadineChief Operating Officer
Option Exercise
3,51444,753(D)

View →

Mar 2, 2026Mar 4 10:25 PMSusan RodriguezCCSO
Grant/Award
48,728$53.4748,728(D)

View →